title: Rivastigmine in the treatment of alcohol-induced persisting dementia.
abstract: A case of Alcohol-Induced Persisting Dementia (AIPD) in a 62-year-old man is presented. His progress on treatment with the acetylcholinesterase inhibitor, rivastigmine, is followed. The significant improvement observed suggests that AIPD may be a new indication for this class of drug.
authors.affiliation: Department of Community Health and Psychiatry, Section of Psychiatry, University of the West Indies, Kingston 7, Jamaica, West Indies.
authors.forename: R C
authors.initials: RC
authors.lastname: Gibson
authors.forename: L
authors.initials: L
authors.lastname: Barnaby
mesh_terms: D020268:Alcohol-Induced Disorders, Nervous System / Q000188:drug therapy*; D000544:Alzheimer Disease / Q000188:drug therapy*; D002219:Carbamates / Q000627:therapeutic use*; D002492:Central Nervous System Depressants / Q000009:adverse effects*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D048448:Phenylcarbamates; D000068836:Rivastigmine
chemical_list: D002219:Carbamates; D002492:Central Nervous System Depressants; D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000431:Ethanol; D000068836:Rivastigmine